Sexual health and sexual satisfaction is an important part of an individual's overall physical and emotional well being. For many men, their ejaculation is difficult and sometimes impossible to control, and thus ejaculation occurs relatively quickly. If this occurs prior to the woman achieving sexual satisfaction, then frustration can result. This frustration can be shared by the man as well. If this frustration continues, then relationship problems can occur. If a man ejaculates before he desires or is ready, or before he can satisfy his partner, then the condition is termed Early or Premature Ejaculation (P.E.).
Deferol™ Climax Control Supplement is a product designed to allow a man to have more control over his climax. To determine the effectiveness of Deferol™, the company is currently engaged in ongoing clinical trials comparing Deferol™ to placebo using a randomized placebo-controlled double blind crossover study. This is an in-home study using only one Deferol™ capsule prior to intercourse and comparing intercourse time to that of one placebo capsule. In an effort to eliminate placebo skew, the subjects were not told one capsule was a placebo. The subjects believed both capsules they were testing were active Deferol™. Subjects were asked to measure their intercourse time, defined as the time of initial vaginal penetration with the penis until ejaculation, for each capsule taken.
Currently, 29 normal healthy males ranging in age from 18 to 44 years with intercourse times ranging from 4 minutes to 45 minutes have completed the study. Statistical analysis shows a statistically significant increase in intercourse time with Deferol™ over placebo.1 This study shows Deferol™ is clinically effective as a climax control supplement under the most rigorous test of efficacy possible of just one capsule one hour prior to intercourse.
Deferol™ Climax Control Supplement would be most appealing to men with relatively short intercourse times. In an analysis of the subgroup of men with self-reported intercourse times of less than 15 minutes, one Deferol™ capsule prior to sex showed an average 40% increase in intercourse time.2
Additional studies are underway to assess the effectiveness of Deferol™. These studies involve evaluating the effectiveness of multiple doses of Deferol™ and evaluating the effectiveness of daily administration of Deferol™. Based on the current results seen with just one dose of Deferol™, the company expects even more compelling results with these studies.
1 n=29, statistically significant (P=0.006), paired t-Test
2 n=17, statistically significant (P=0.031), paired t-Test